Skip to Content

RP 067 (Fenofibrate (micronized) 67 mg)

Pill with imprint RP 067 is Pink, Capsule-shape and has been identified as Fenofibrate (micronized) 67 mg. It is supplied by Rhodes Pharmaceuticals.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 67 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for RP 067

Fenofibrate (micronized)

Imprint:
RP 067
Strength:
67 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Rhodes Pharmaceuticals
Manufacturer:
Teva Canada Limited
National Drug Code (NDC):
42858-0067

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide